BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 2858110)

  • 1. Cimetidine, ranitidine and mifentidine in specific gastric and duodenal ulcer models.
    Del Soldato P; Ghiorzi A; Cereda E; Donetti A
    Pharmacology; 1985; 30(1):45-51. PubMed ID: 2858110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of the new H2-receptor antagonist mifentidine on gastric secretion, gastric emptying and experimental gastric and duodenal ulcers in the rat: comparison with cimetidine and ranitidine.
    Scarpignato C; Tangwa M; Tramacere R; Del Soldato P
    Digestion; 1986; 33(1):7-16. PubMed ID: 2866139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the new H2-receptor antagonist mifentidine on gastric acid secretion in the cat: comparison with cimetidine and ranitidine.
    Scarpignato C; Tramacere R; Tangwa M; Bertaccini G
    Arch Int Pharmacodyn Ther; 1985 Jul; 276(1):142-51. PubMed ID: 2864903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal ulceration in the guinea pig in response to dimaprit, histamine, and H1- and H2-blocking agents.
    Cho CH; Pfeiffer CJ
    Dig Dis Sci; 1981 Apr; 26(4):306-11. PubMed ID: 6113104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of a new histamine H2-receptor antagonist, ranitidine, on experimental acute gastric and duodenal ulcers (author's transl)].
    Okabe S; Kunimi H; Ohtsuki H
    Nihon Yakurigaku Zasshi; 1981 Apr; 77(4):397-406. PubMed ID: 6116654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cimetidine, a histamine H2-receptor antagonist, on various experimental gastric and duodenal ulcers.
    Okabe S; Takeuchi K; Urushidani T; Takagi K
    Am J Dig Dis; 1977 Aug; 22(8):677-84. PubMed ID: 18007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of mifentidine on mepirizole-induced duodenal ulcer in the rat.
    Brambilla A; Ghiorzi A; De Paoli AM; Giachetti A
    Pharmacol Res Commun; 1987 Dec; 19(12):877-85. PubMed ID: 2896364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathogenesis, diagnosis and therapy of ulcer disease. Therapy. 4: Pharmacological basis and therapy with H2 antagonist].
    Med Welt; 1983 Dec; 34(49):20, 22. PubMed ID: 6140616
    [No Abstract]   [Full Text] [Related]  

  • 9. H2-receptor antagonists: development and application.
    Feldman S
    N Engl Reg Allergy Proc; 1986; 7(4):362-6. PubMed ID: 2886903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ranitidine, a new H2-antagonist, on gastric and pancreatic secretion in duodenal ulcer patients.
    Konturek SJ; Obtułowicz W; Kwiecień N; Sito E; Oleksy J; Miszczuk-Jamska B
    Dig Dis Sci; 1980 Oct; 25(10):737-43. PubMed ID: 6107221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy and prevention of duodenal and gastric ulcer with histamine-H2-receptor antagonists].
    Hentschel E
    Wien Med Wochenschr; 1983; 133(4-5):104-7. PubMed ID: 6134397
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacology of mifentidine, a novel H2-receptor antagonist.
    Pagani F; Micheletti R; Brambilla A; Schiavone A; Montagna E; Ciprandi C; Giachetti A
    Arzneimittelforschung; 1985; 35(1A):451-5. PubMed ID: 2859036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic analysis of the interaction of mifentidine with gastric H2-receptors in the conscious dog.
    Pagani F; Zecca M; Giachetti A
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Sep; 336(3):349-51. PubMed ID: 2891046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology and clinical efficacy of ranitidine, a new H2-receptor antagonist.
    Helman CA; Tim LO
    Pharmacotherapy; 1983; 3(4):185-92. PubMed ID: 6136952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of gastric ulcer relapse induced by indomethacin in rats by a mutein of basic fibroblast growth factor.
    Satoh H; Asano S; Maeda R; Murakami I; Inada I; Sato F; Shino A
    Jpn J Pharmacol; 1997 Mar; 73(3):229-41. PubMed ID: 9127818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bedtime treatment of duodenal ulcer.
    Drug Ther Bull; 1985 Dec; 23(24):95-6. PubMed ID: 2866081
    [No Abstract]   [Full Text] [Related]  

  • 17. New horizons in the pharmacologic management of peptic ulceration.
    Debas HT; Mulholland MW
    Am J Surg; 1986 Mar; 151(3):422-30. PubMed ID: 2869709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of action of H2-antagonists on histamine- or dimaprit-stimulated H2-receptors of spontaneously beating guinea-pig atrium.
    Krielaart MJ; Veenstra DM; van Buuren KJ
    Agents Actions; 1990 Aug; 31(1-2):23-35. PubMed ID: 1704683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ranitidine and cimetidine for duodenal ulcer.
    Langman MJ; Henry DA; Ogilvie A
    Scand J Gastroenterol Suppl; 1981 Jun; 69():115-7. PubMed ID: 6119774
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative study of mifentidine and ranitidine in the short-term treatment of duodenal ulcer.
    Sabbatini F; Lazzaroni M; Petrillo M; Piai G; Mazzacca G; Bianchi Porro G
    Eur J Clin Pharmacol; 1990; 39(5):515-7. PubMed ID: 1981748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.